Stock Analysis on Net
Stock Analysis on Net

Johnson & Johnson (NYSE:JNJ)

$24.99

Net Profit Margin
since 2005

Microsoft Excel

Paying user area

Try for free

Johnson & Johnson pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

Johnson & Johnson, net profit margin, long-term trends, calculation

Microsoft Excel
Net profit margin = 100 × Net earnings1 ÷ Sales to customers1
Dec 28, 2025 = 100 × ÷
Dec 29, 2024 = 100 × ÷
Dec 31, 2023 = 100 × ÷
Dec 31, 2022 = 100 × ÷
Dec 31, 2021 = 100 × ÷
Dec 31, 2020 = 100 × ÷
Dec 29, 2019 = 100 × ÷
Dec 30, 2018 = 100 × ÷
Dec 31, 2017 = 100 × ÷
Dec 31, 2016 = 100 × ÷
Dec 31, 2015 = 100 × ÷
Dec 28, 2014 = 100 × ÷
Dec 29, 2013 = 100 × ÷
Dec 30, 2012 = 100 × ÷
Dec 31, 2011 = 100 × ÷
Dec 31, 2010 = 100 × ÷
Dec 31, 2009 = 100 × ÷
Dec 28, 2008 = 100 × ÷
Dec 30, 2007 = 100 × ÷
Dec 31, 2006 = 100 × ÷
Dec 31, 2005 = 100 × ÷

Based on: 10-K (reporting date: 2025-12-28), 10-K (reporting date: 2024-12-29), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$ in millions

The net profit margin exhibited considerable fluctuation over the period from 2005 to 2025. Initially, the margin demonstrated relative stability, followed by a period of volatility and a significant peak in recent years. A detailed examination reveals distinct phases in its performance.

Initial Stability & Decline (2005-2007)
From 2005 to 2006, the net profit margin remained consistently high, fluctuating between 20.61% and 20.73%. However, a noticeable decline occurred in 2007, dropping to 17.31%. This represents the first significant deviation from the prior trend.
Recovery & Peak (2008-2016)
The margin recovered in 2008, reaching 20.31%, and continued to trend upwards, peaking at 23.01% in 2016. This period indicates a strong ability to translate sales into profit. The years 2014 through 2016 show particularly strong and consistent performance, with margins exceeding 21.9% each year.
Dramatic Decline & Recovery (2017-2019)
A substantial and abrupt decrease in net profit margin was observed in 2017, falling to a low of 1.70%. While the margin recovered somewhat in the following two years, reaching 18.75% and 18.42% in 2018 and 2019 respectively, it did not return to the levels seen prior to 2017. This suggests a significant disruption to profitability in 2017, the cause of which would require further investigation.
Recent Volatility & Peak (2020-2025)
The period from 2020 to 2025 demonstrates increased volatility. The margin rose to 22.26% in 2020, decreased to 18.90% in 2021, then experienced a dramatic increase to 41.28% in 2022. This was followed by a decrease to 15.84% in 2023 and a further increase to 28.46% in 2025. The substantial increase in 2022 warrants further scrutiny to understand the underlying drivers. The most recent value suggests a return to a higher level of profitability, but remains below the peak observed in 2022.

Overall, the net profit margin has demonstrated a complex pattern over the analyzed timeframe. While periods of strong profitability were evident, significant fluctuations, particularly in 2017 and 2022-2025, indicate potential areas for further financial investigation.

Comparison to Competitors

Johnson & Johnson, net profit margin, long-term trends, comparison to competitors

Microsoft Excel
Johnson & Johnson AbbVie Inc. Amgen Inc. Bristol-Myers Squibb Co. Danaher Corp. Eli Lilly & Co. Gilead Sciences Inc. Merck & Co. Inc. Pfizer Inc. Regeneron Pharmaceuticals Inc. Thermo Fisher Scientific Inc. Vertex Pharmaceuticals Inc.
Dec 28, 2025
Dec 29, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 29, 2019
Dec 30, 2018
Dec 31, 2017
Dec 31, 2016
Dec 31, 2015
Dec 28, 2014
Dec 29, 2013
Dec 30, 2012
Dec 31, 2011
Dec 31, 2010
Dec 31, 2009
Dec 28, 2008
Dec 30, 2007
Dec 31, 2006
Dec 31, 2005

Based on: 10-K (reporting date: 2025-12-28), 10-K (reporting date: 2024-12-29), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)

Johnson & Johnson, net profit margin, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)

Microsoft Excel
Johnson & Johnson Pharmaceuticals, Biotechnology & Life Sciences
Dec 28, 2025
Dec 29, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 29, 2019
Dec 30, 2018
Dec 31, 2017
Dec 31, 2016
Dec 31, 2015
Dec 28, 2014
Dec 29, 2013
Dec 30, 2012
Dec 31, 2011
Dec 31, 2010
Dec 31, 2009
Dec 28, 2008
Dec 30, 2007
Dec 31, 2006
Dec 31, 2005

Based on: 10-K (reporting date: 2025-12-28), 10-K (reporting date: 2024-12-29), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Comparison to Industry (Health Care)

Johnson & Johnson, net profit margin, long-term trends, comparison to industry (health care)

Microsoft Excel
Johnson & Johnson Health Care
Dec 28, 2025
Dec 29, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 29, 2019
Dec 30, 2018
Dec 31, 2017
Dec 31, 2016
Dec 31, 2015
Dec 28, 2014
Dec 29, 2013
Dec 30, 2012
Dec 31, 2011
Dec 31, 2010
Dec 31, 2009
Dec 28, 2008
Dec 30, 2007
Dec 31, 2006
Dec 31, 2005

Based on: 10-K (reporting date: 2025-12-28), 10-K (reporting date: 2024-12-29), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).